Patents by Inventor Alexandr Anatolyevich Litvin

Alexandr Anatolyevich Litvin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monovalent and divalent salts of N-(5-hydroxynicotinoil) -L-glutamic acid exhibiting psychotropic (antidepressant and anxiolytic), neuroprotective, geroprotective and cerebroprotective action
    Patent number: 8030493
    Abstract: The invention relates to medicine, in particular to mono- and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic antidepressant, anxiolytic, heroprotective, neuroprotective, antihypoxia cerebroprotective and nootropic action. The novel compounds differ from the known preparations, including the closest prior art in the form of a N-(5-hydroxynicotinoil)-L-glutaminic acid base (nooglucotyl), in that they produce psychotropic effects, namely antidepressant, anxiolytic, neuroprotective and heroprotective actions, in such a way that lesion focuses caused by apoplectic attacks are reduced and age-specific neurological deficiencies and intellectual and physical work capacities are improved.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: October 4, 2011
    Assignee: Obschestvo S Ogranichennoy Otvetstvennostyu “Natsionalnaya Isseldovatelskaya Kompaniya”
    Inventors: Pavel Vasilyevich Yakimuk, Sergey Vitalyevich Stovbun, Alexandr Anatolyevich Litvin
  • Monovalent and Divalent Salts of N-(5-Hydroxynicotinoil) -L-Glutamic Acid Exhibiting Psychotropic (Antidepressant and Anxiolytic), Neuroprotective, Geroprotective and Cerebroprotective Action
    Publication number: 20090240059
    Abstract: The invention relates to medicine, in particular to mono- and divalent salts of N-(5-hydroxynicotinoil)-L-glutaminic acid exhibiting psychotropic antidepressant, anxiolytic, heroprotective, neuroprotective, antihypoxia cerebroprotective and nootropic action. The novel compounds differ from the known preparations, including the closest prior art in the form of a N-(5-hydroxynicotinoil)-L-glutaminic acid base (nooglucotyl), in that they produce psychotropic effects, namely antidepressant, anxiolytic, neuroprotective and heroprotective actions, in such a way that lesion focuses caused by apoplectic attacks are reduced and age-specific neurological deficiencies and intellectual and physical work capacities are improved.
    Type: Application
    Filed: June 6, 2007
    Publication date: September 24, 2009
    Applicant: OBSCHESTVO S OGRANICHENNOY OTVESTVENNOSTYU " NATSIONALNAYA ISSLEDOVATELSKAYA KOMPANIYA"
    Inventors: Pavel Vasilyevich Yakimuk, Sergey Vitalyevich Stovbun, Alexandr Anatolyevich Litvin